The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(tert-butylcarbamoyl)piperidin-4-yl)-N-(4-(6-methoxypyrazolo[1,5-a]pyridine-3-carboxamido)-3-methylphenyl)-1H-indazole-3-carboxamide ID: ALA4582324
PubChem CID: 155562023
Max Phase: Preclinical
Molecular Formula: C34H38N8O4
Molecular Weight: 622.73
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)NC(C)(C)C)CC5)c5ccccc45)cc3C)cnn2c1
Standard InChI: InChI=1S/C34H38N8O4/c1-21-18-22(10-12-27(21)37-31(43)26-19-35-41-20-24(46-5)11-13-28(26)41)36-32(44)30-25-8-6-7-9-29(25)42(39-30)23-14-16-40(17-15-23)33(45)38-34(2,3)4/h6-13,18-20,23H,14-17H2,1-5H3,(H,36,44)(H,37,43)(H,38,45)
Standard InChI Key: DEGODTVDGRTRCG-UHFFFAOYSA-N
Molfile:
RDKit 2D
46 51 0 0 0 0 0 0 0 0999 V2000
14.3655 -29.3322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3643 -30.1517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0724 -30.5607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0706 -28.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7792 -29.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7840 -30.1472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5640 -30.3956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0414 -29.7305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5563 -29.0711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5502 -28.2509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2548 -27.8370 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8395 -27.8475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8334 -27.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5401 -26.6201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5344 -25.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8231 -25.3996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1161 -25.8178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1253 -26.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8159 -24.5824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5201 -24.1676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5129 -23.3505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2313 -24.5700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3245 -25.3817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1253 -25.5446 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9755 -24.2309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5243 -24.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3192 -24.6601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5664 -23.8831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0126 -23.2801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2198 -23.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4661 -26.2864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9904 -26.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3272 -27.6927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1407 -27.7740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6164 -27.1084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2785 -26.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4779 -28.5184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0019 -29.1826 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2912 -28.5985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6284 -29.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4416 -29.4231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1523 -30.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8384 -30.1288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4224 -27.0497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6563 -30.5597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9489 -30.1506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
9 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
20 21 2 0
20 22 1 0
22 23 2 0
23 24 1 0
24 26 1 0
25 22 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
31 32 1 0
31 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
24 31 1 0
34 37 1 0
37 38 2 0
37 39 1 0
39 40 1 0
40 41 1 0
40 42 1 0
40 43 1 0
18 44 1 0
2 45 1 0
45 46 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 622.73Molecular Weight (Monoisotopic): 622.3016AlogP: 5.65#Rotatable Bonds: 6Polar Surface Area: 134.89Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: ┄CX Basic pKa: 0.77CX LogP: 4.07CX LogD: 4.07Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.22Np Likeness Score: -1.73
References 1. O'Malley DP, Ahuja V, Fink B, Cao C, Wang C, Swanson J, Wee S, Gavai AV, Tokarski J, Critton D, Paiva AA, Johnson BM, Szapiel N, Xie D.. (2019) Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase., 10 (10): [PMID:31620238 ] [10.1021/acsmedchemlett.9b00354 ]